Concepedia

Joanne Joergensen

JJ

Statistics

Publications

12

Citations

583

H-Index

12

Active since

1994

Affiliations

Novartis (Switzerland)(Current)

Joanne Joergensen is an author at Novartis (Switzerland) specializing in medicine, vascular biology, and transplantation.

Top concepts

Publications per year

1994–2004

12

Publications

12

Immunosuppressive TOR kinase inhibitor everolimus (RAD) suppresses growth of cells derived from posttransplant lymphoproliferative disorder at allograft-protecting doses

Mirosław Majewski, Magdalena Korecka, Joanne Joergensen et al. · Transplantation · 2003 · 156 citations

Acute rejection of vascular heart allografts by perforin‐deficient mice

Manfred Schulz, Henk‐Jan Schuurman, Joanne Joergensen et al. · European Journal of Immunology · 1995 · 96 citations

, , +19

CONTRIBUTION OF DONOR-SPECIFIC ANTIBODIES TO ACUTE ALLOGRAFT REJECTION

Daniel Br ndle, Joanne Joergensen, Gerhard Zenke et al. · Transplantation · 1998 · 62 citations

The chemokine receptor CCR7 controls lymph node‐dependent cytotoxic T cell priming in alloimmune responses

Uta E. Höpken, Jana Droese, Jianping Li et al. · European Journal of Immunology · 2004 · 59 citations · Full text

The immunosuppressant rapamycin blocks in vitro responses to hematopoietic cytokines and inhibits recovering but not steady-state hematopoiesis in vivo

VF Quesniaux, S Wehrli, C. W. Steiner et al. · Blood · 1994 · 50 citations · Full text

1–5 of 12